HomeFLGT • NASDAQ
Fulgent Genetics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 73.46M | 13.92% |
Operating expense | 48.14M | 9.66% |
Net income | -11.53M | 14.35% |
Net profit margin | -15.69 | 24.86% |
Earnings per share | 0.04 | 500.00% |
EBITDA | -13.88M | 8.32% |
Effective tax rate | -1.50% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 320.32M | 4.78% |
Total assets | 1.21B | -1.96% |
Total liabilities | 82.97M | -19.63% |
Total equity | 1.12B | — |
Shares outstanding | 30.44M | — |
Price to book | 0.58 | — |
Return on assets | -4.08% | — |
Return on capital | -4.36% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -11.53M | 14.35% |
Cash from operations | -4.43M | -160.98% |
Cash from investing | 27.73M | 158.77% |
Cash from financing | -11.17M | -298.00% |
Net change in cash | 12.14M | 128.36% |
Free cash flow | -8.52M | -204.78% |
Previous close
$21.22
Day range
$20.68 - $21.16
Year range
$14.57 - $25.11
Market cap
635.66M USD
Avg Volume
388.81K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
CEO
Founded
2011
Headquarters
Website
Employees
1,313
